Seres Therapeutics, Inc. Cash and Cash Equivalents
Seres Therapeutics, Inc. (MCRB) had Cash and Cash Equivalents of $15.59 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $15.59M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $29.83M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $45.77M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $47.64M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $15.59M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $29.83M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $45.77M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $47.64M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $45.38M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $58.85M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $30.79M 10-K · filed 2026-03-12 |
| 2024-09-30 | $66.82M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $71.23M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $111.18M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $127.97M 10-K · filed 2025-03-13 |
| 2023-09-30 | $169.91M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $229.52M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $94.84M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $163.03M 8-K · filed 2024-08-15 |
| 2022-09-30 | $205.40M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $126.82M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $153.19M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $180.00M 10-K · filed 2023-03-07 |
| 2021-09-30 | $227.46M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $74.00M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $66.58M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $116.05M 10-K · filed 2022-03-01 |
| 2020-09-30 | $207.33M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $61.54M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $54.86M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $65.13M 10-K · filed 2021-03-02 |
| 2019-09-30 | $49.30M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $102.23M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $53.60M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $85.82M 10-K · filed 2020-03-02 |
| 2018-09-30 | $55.71M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $57.96M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $47.19M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $36.09M 10-K · filed 2019-03-06 |
| 2017-09-30 | $46.02M 10-Q · filed 2018-11-08 |
| 2017-06-30 | $33.64M 10-Q · filed 2018-08-02 |
| 2017-03-31 | $41.90M 10-Q · filed 2018-05-09 |
| 2016-12-31 | $54.54M 10-K · filed 2019-03-06 |
| 2016-09-30 | $55.61M 10-Q · filed 2017-11-08 |
| 2016-06-30 | $59.82M 10-Q · filed 2017-08-03 |
| 2016-03-31 | $193.23M 10-Q · filed 2017-05-04 |
| 2015-12-31 | $73.93M 10-K · filed 2019-03-06 |
| 2015-09-30 | $69.70M 10-Q · filed 2016-11-10 |
| 2015-06-30 | $36.34M 10-Q · filed 2016-08-11 |
| 2015-03-31 | $45.05M 10-Q · filed 2016-05-16 |
| 2014-12-31 | $114.19M 10-K · filed 2018-03-08 |
| 2014-09-30 | $7.12M 10-Q · filed 2015-11-12 |
| 2014-06-30 | $9.80M 10-Q · filed 2015-08-10 |
| 2013-12-31 | $1.65M 10-K · filed 2017-03-16 |
| 2012-12-31 | $6.21M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |